Role of the MAPKs/TGF-β1/TRAF6 Signaling Pathway in Atrial Fibrosis of Patients with Chronic Atrial Fibrillation and Rheumatic Mitral Valve Disease

Publisher： Karger

E-ISSN： 1421-9751|129|4|216-223

ISSN： 0008-6312

Source： Cardiology, Vol.129, Iss.4, 2014-11, pp. : 216-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eplerenone Prevents Atrial Fibrosis via the TGF-β Signaling Pathway

By  

Cardiology, Vol. 138, Iss. 1, 2017-06 ,pp. : 55-62

Karger

Access to resources Recommend Favorite

The Human Atrial Fibrosis Pathway in the Development of Atrial Fibrillation

By  

Cardiology, Vol. 136, Iss. 2, 2016-08 ,pp. : 77-78

Karger

Access to resources Recommend Favorite

Ventricular Reverse Remodeling Early after Mitral Valve Repair for Severe Chronic Mitral Regurgitation with Atrial Fibrillation

By  

Cardiology, Vol. 114, Iss. 2, 2009-06 ,pp. : 132-141

Karger

Access to resources Recommend Favorite

The Role of Platelet-Derived Growth Factor-B/Platelet-Derived Growth Factor Receptor-β Signaling in Chronic Atrial Fibrillation

By  

Cardiology, Vol. 133, Iss. 4, 2016-01 ,pp. : 242-256

Karger

Access to resources Recommend Favorite

Pouched Mitral Isthmus Is Associated with Incomplete Linear Block in Atrial Fibrillation Patients with Mechanical Mitral Valve Replacement

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 5, 2015-05 ,pp. : 501-508

John Wiley & Sons Inc

Access to resources Recommend Favorite